SoftBank is teaming up with Saudi Arabia’s sovereign wealth fund to invest up to $100 billion in tech companies over the next five years.
A council chaired by President Obama has called for countries to cooperate to investigate the potential uses of artificial intelligence in healthcare.
Elemental Machines is shipping its sensor-enabled smart lab system to cut the time it takes to pinpoint causes of variability and reproducibility problems.
Merck KGaA has added a fresh batch of startups to its incubator, including firms focused on automating data transfers and facilitating lab equipment sharing.
Uber and its rival Lyft were both at DPharm Disruptive Innovation US to pitch themselves as the answer to an enduring inefficiency in clinical trials.
Antidote, the tech startup formerly known as TrialReach, is gearing up to introduce a tool to automatically match patients’ EHRs to clinical trials.
AOBiome is running an iPhone-enabled Phase IIb trial of its bacterial treatment for acne with Novartis ($NVS)-backed virtual trial CRO Science 37.
Tute Genomics is crowdfunding a DNA sequencing scheme. The campaign is aiming to raise $100,000 by offering whole genome sequencing for between $999 and $1,499.
Medidata has signed up to provide its cloud platform and mobile health capabilities to Techfields Pharma.
Trialbee has added ex-Lundbeck CEO Ulf Wiinberg and former Bristol-Myers Squibb SVP Lars Birgerson to its board of directors.